BackNeueHealth Overview

NeueHealth Current Cash

NeueHealth's current cash is $130M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$131.62M
↓ 1.35% YoYΔ $-1.81M vs prior year quarter

Peer average / median

Loading

NeueHealth Current Cash History

Loading

NeueHealth vs. peers: Current Cash Comparison

Loading

NeueHealth Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NeueHealth (NEUE) FAQ

NeueHealth (NEUE) currently reports a current cash of $130M as of June 2025. That compares with $130M in the prior-year period — down 1.4% year over year. Use the charts on this page to explore NeueHealth's current cash history and peer comparisons.

NeueHealth's current cash decreased from $130M to $130M — a 1.4% year-over-year decrease (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeueHealth reported $130M in current cash as of June 2025. That compares with $130M in the prior-year period — down 1.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeueHealth, and consider following NEUE for alerts when major investors trade the stock.

NeueHealth is classified in the Finance sector. On current cash, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing NEUE with unrelated industries.